The global mycoplasma testing market is expected to grow from USD 0.66 billion in 2019 to USD 16.99 billion by 2027, at a CAGR of 12.5% during the forecast period 2020-2027.
Mycoplasma is responsible for the contamination in tissue engineering, cultivation of stem cells and biopharmaceutical production. To investigate metabolism alterations, chromosomal aberrations, morphological changes and altered growth rates, biotechnology and pharmaceutical companies performs mycoplasma testing. It is used for raw materials, cell banks, final as well as bulk drug products. It is carried out in the production and research activities of biopharmaceutical products. The mycoplasma testing market is driven by the growth in the biotechnology and pharmaceutical sector. Also, a rise in the culture contamination, technological advancements as well as increased investments by the organizations in research and development activities are contributing to the growth of the mycoplasma testing market.
This study delivers a comprehensive analysis of technologies, applications and regions. The technology segment includes enzymatic methods, microbial culture techniques, indirect assay, direct assay, ELISA and PCR. PCR segment has the highest growth in the mycoplasma testing market. It is used to detect multiple mycoplasma species by separating contaminating DNA. It offers high efficiency, rapid detection, ease of procedure and specificity. Merck KGaA developed LookOut Mycoplasma PCR detection kit which is used to detect acholeplasma, mycoplasma and ureaplasma contamination in cell culture lines and cell-derived biologicals. The application segment includes end of production cells testing, virus testing and cell line testing. Cell line testing has the highest growth in the mycoplasma testing market. It is due to a rise in the research activities as well as mycoplasma contamination in cell culture. Mycoplasma contamination is responsible for developing toxins and alterations in metabolite formations in cell culture. Hence, it plays a vital role in biopharmaceutical industries.
The market has been divided into North America, Europe, Asia-Pacific, Middle East & Africa, and South America. North America has the highest share in the mycoplasma testing market as the government is investing huge amount of money in biopharmaceutical industries in order to facilitate research-based activities. It results in generating higher demand along with an increased production of biopharmaceuticals which needs highly purified cultures in the region.
Some of the notable players in the mycoplasma testing market are Lonza Group Ltd., PromoCell GmbH, Biological Industries Israel Beit Haemek Ltd, Thermo Fisher Scientific, InvivoGen, Charles River Laboratories International Inc., Merck KGaA, Bionique Testing Laboratories Inc. And American Type Culture Collection. Key players are focusing on various strategies such as geographical expansions, new product development, mergers and acquisitions. Lonza launched Lucetta 2-a product which is used to simplify and accelerate the detection of mycoplasma in cell cultures in order to expand its product portfolio.
This study forecasts revenue growth at global, regional, and country levels from 2020 to 2027. Fior Markets has segmented the market based on below-mentioned segments:
Global Mycoplasma Testing Market Analysis And Forecast, By Technology
Global Mycoplasma Testing Market Analysis And Forecast, By Application
Global Mycoplasma Testing Market Analysis And Forecast, By Regional Analysis
Report Description:
1. Introduction
1.1. Objectives of the Study
1.2. Market Definition
1.3. Research Scope
1.4. Currency
1.5. Key Target Audience
2. Research Methodology and Assumptions
3. Executive Summary
4. Premium Insights
4.1. Porter’s Five Forces Analysis
4.2. Value Chain Analysis
4.3. Top Investment Pockets
4.3.1. Market Attractiveness Analysis By Technology
4.3.2. Market Attractiveness Analysis By Application
4.3.3. Market Attractiveness Analysis By Region
4.4. Industry Trends
5. Market Dynamics
5.1. Market Evaluation
5.2. Drivers
5.3. Restrains
5.4. Challenges
5.5. Opportunities
6. Global Mycoplasma Testing Market Analysis and Forecast, By Technology
6.1. Segment Overview
6.2. Enzymatic Methods
6.3. Microbial Culture Techniques
6.4. Indirect Assay
6.5. Direct Assay
6.6. ELISA
6.7. PCR
7. Global Mycoplasma Testing Market Analysis and Forecast, By Application
7.1. Segment Overview
7.2. End of Production Cells Testing
7.3. Virus Testing
7.4. Cell Line Testing
8. Global Mycoplasma Testing Market Analysis and Forecast, By Regional Analysis
8.1. Segment Overview
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. U.K.
8.3.4. Italy
8.3.5. Spain
8.4. Asia-Pacific
8.4.1. Japan
8.4.2. China
8.4.3. India
8.5. South America
8.5.1. Brazil
8.6. Middle East and Africa
8.6.1. UAE
8.6.2. South Africa
9. Global Mycoplasma Testing Market-Competitive Landscape
9.1. Overview
9.2. Market Share of Key Players in Global Mycoplasma Testing Market
9.2.1. Global Company Market Share
9.2.2. North America Company Market Share
9.2.3. Europe Company Market Share
9.2.4. APAC Company Market Share
9.3. Competitive Situations and Trends
9.3.1. Product Launches and Developments
9.3.2. Partnerships, Collaborations, and Agreements
9.3.3. Mergers & Acquisitions
9.3.4. Expansions
10. Company Profiles
10.1. Lonza Group Ltd
10.1.1. Business Overview
10.1.2. Company Snapshot
10.1.3. Company Market Share Analysis
10.1.4. Company Product Portfolio
10.1.5. Recent Developments
10.1.6. SWOT Analysis
10.2. PromoCell GmbH
10.2.1. Business Overview
10.2.2. Company Snapshot
10.2.3. Company Market Share Analysis
10.2.4. Company Product Portfolio
10.2.5. Recent Developments
10.2.6. SWOT Analysis
10.3. Biological Industries Israel Beit Haemek Ltd,
10.3.1. Business Overview
10.3.2. Company Snapshot
10.3.3. Company Market Share Analysis
10.3.4. Company Product Portfolio
10.3.5. Recent Developments
10.3.6. SWOT Analysis
10.4. Thermo Fisher Scientific
10.4.1. Business Overview
10.4.2. Company Snapshot
10.4.3. Company Market Share Analysis
10.4.4. Company Product Portfolio
10.4.5. Recent Developments
10.4.6. SWOT Analysis
10.5. InvivoGen,
10.5.1. Business Overview
10.5.2. Company Snapshot
10.5.3. Company Market Share Analysis
10.5.4. Company Product Portfolio
10.5.5. Recent Developments
10.5.6. SWOT Analysis
10.6. Charles River Laboratories International Inc.,
10.6.1. Business Overview
10.6.2. Company Snapshot
10.6.3. Company Market Share Analysis
10.6.4. Company Product Portfolio
10.6.5. Recent Developments
10.6.6. SWOT Analysis
10.7. Merck KGaA
10.7.1. Business Overview
10.7.2. Company Snapshot
10.7.3. Company Market Share Analysis
10.7.4. Company Product Portfolio
10.7.5. Recent Developments
10.7.6. SWOT Analysis
10.8. Bionique Testing Laboratories Inc
10.8.1. Business Overview
10.8.2. Company Snapshot
10.8.3. Company Market Share Analysis
10.8.4. Company Product Portfolio
10.8.5. Recent Developments
10.8.6. SWOT Analysis
List of Table
1. Global Mycoplasma Testing Market, By Technology, 2017-2027 (USD Billion)
2. Global Enzyamatic Method, Mycoplasma Testing Market, By Region, 2017-2027 (USD Billion)
3. Global Microbial Culture Techniques, Mycoplasma Testing Market, By Region, 2017-2027 (USD Billion)
4. Global Indirect Assay, Mycoplasma Testing Market, By Region, 2017-2027 (USD Billion)
5. Global Direct Assay, Mycoplasma Testing Market, By Region, 2017-2027 (USD Billion)
6. Global ELIZA, Mycoplasma Testing Market, By Region, 2017-2027 (USD Billion)
7. Global PCR, Mycoplasma Testing Market, By Region, 2017-2027 (USD Billion)
8. Global Mycoplasma Testing Market, By Application, 2017-2027 (USD Billion)
9. Global End of Production Cell Testing Mycoplasma Testing Market, By Region, 2017-2027 (USD Billion)
10. Global Virus Testing Mycoplasma Testing Market, By Region, 2017-2027 (USD Billion)
11. Global Cell Line Testing Mycoplasma Testing Market, By Region, 2017-2027 (USD Billion)
12. North America Mycoplasma Testing Market, By Technology, 2017-2027 (USD Billion)
13. North America Mycoplasma Testing Market, By Application, 2017-2027 (USD Billion)
14. U.S. Mycoplasma Testing Market, By Technology, 2017-2027 (USD Billion)
15. U.S. Mycoplasma Testing Market, By Application, 2017-2027 (USD Billion)
16. Canada Mycoplasma Testing Market, By Technology, 2017-2027 (USD Billion)
17. Canada Mycoplasma Testing Market, By Application, 2017-2027 (USD Billion)
18. Mexico Mycoplasma Testing Market, By Technology, 2017-2027 (USD Billion)
19. Mexico Mycoplasma Testing Market, By Application, 2017-2027 (USD Billion)
20. Europe Mycoplasma Testing Market, By Technology, 2017-2027 (USD Billion)
21. Europe Mycoplasma Testing Market, By Application, 2017-2027 (USD Billion)
22. Germany Mycoplasma Testing Market, By Technology, 2017-2027 (USD Billion)
23. Germany Mycoplasma Testing Market, By Application, 2017-2027 (USD Billion)
24. France Mycoplasma Testing Market, By Technology, 2017-2027 (USD Billion)
25. France Mycoplasma Testing Market, By Application, 2017-2027 (USD Billion)
26. U.K. Mycoplasma Testing Market, By Technology, 2017-2027 (USD Billion)
27. U.K. Mycoplasma Testing Market, By Application, 2017-2027 (USD Billion)
28. Italy Mycoplasma Testing Market, By Technology, 2017-2027 (USD Billion)
29. Italy Mycoplasma Testing Market, By Application, 2017-2027 (USD Billion)
30. Spain Mycoplasma Testing Market, By Technology, 2017-2027 (USD Billion)
31. Spain Mycoplasma Testing Market, By Application, 2017-2027 (USD Billion)
32. Asia Pacific Mycoplasma Testing Market, By Technology, 2017-2027 (USD Billion)
33. Asia Pacific Mycoplasma Testing Market, By Application, 2017-2027 (USD Billion)
34. Japan Mycoplasma Testing Market, By Technology, 2017-2027 (USD Billion)
35. Japan Mycoplasma Testing Market, By Application, 2017-2027 (USD Billion)
36. China Mycoplasma Testing Market, By Technology, 2017-2027 (USD Billion)
37. China Mycoplasma Testing Market, By Application, 2017-2027 (USD Billion)
38. India Mycoplasma Testing Market, By Technology, 2017-2027 (USD Billion)
39. India Mycoplasma Testing Market, By Application, 2017-2027 (USD Billion)
40. South America Mycoplasma Testing Market, By Technology, 2017-2027 (USD Billion)
41. South America Mycoplasma Testing Market, By Application, 2017-2027 (USD Billion)
42. Brazil Mycoplasma Testing Market, By Technology, 2017-2027 (USD Billion)
43. Brazil Mycoplasma Testing Market, By Application, 2017-2027 (USD Billion)
44. Middle East and Africa Mycoplasma Testing Market, By Technology, 2017-2027 (USD Billion)
45. Middle East and Africa Mycoplasma Testing Market, By Application, 2017-2027 (USD Billion)
46. UAE Mycoplasma Testing Market, By Technology, 2017-2027 (USD Billion)
47. UAE Mycoplasma Testing Market, By Application, 2017-2027 (USD Billion)
48. South Africa Mycoplasma Testing Market, By Technology, 2017-2027 (USD Billion)
49. South Africa Mycoplasma Testing Market, By Application, 2017-2027 (USD Billion)
List of Figures
1. Global Mycoplasma Testing Market Segmentation
2. Global Mycoplasma Testing Market: Research Methodology
3. Market Size Estimation Methodology: Bottom-Up Approach
4. Market Size Estimation Methodology: Top-Down Approach
5. Data Triangulation
6. Porter’s Five Forces Analysis
7. Value Chain Analysis
8. Global Mycoplasma Testing Market Attractiveness Analysis By Technology
9. Global Mycoplasma Testing Market Attractiveness Analysis By Application
10. Global Mycoplasma Testing Market Attractiveness Analysis By Region
11. Global Mycoplasma Testing Market: Dynamics
12. Global Mycoplasma Testing Market Share By Technology(2020 & 2027)
13. Global Mycoplasma Testing Market Share by Application(2020 & 2027)
14. Global Mycoplasma Testing Market Share by Regions (2020 & 2027)
15. Global Mycoplasma Testing Market Share by Company (2019)
Market research is a method of gathering, assessing and deducing data & information about a particular market. Market research is very crucial in these days. The techniques analyze about how a product/service can be offered to the market to its end-customers, observe the impact of that product/service based on the past customer experiences, and cater their needs and demands. Owing to the successful business ventures, accurate, relevant and thorough information is the base for all the organizations because market research report/study offers specific market related data & information about the industry growth prospects, perspective of the existing customers, and the overall market scenario prevailed in past, ongoing present and developing future. It allows the stakeholders and investors to determine the probability of a business before committing substantial resources to the venture. Market research helps in solving the marketing issues challenges that a business will most likely face.
Market research is valuable because of the following reasons:
Our research report features both the aspects; qualitative and quantitative. Qualitative part provides insights about the market driving forces, potential opportunities, customer’s demands and requirement which in turn help the companies to come up with new strategies in order to survive in the long run competition. The quantitative segment offers the most credible information related to the industry. Based on the data gathering, we use to derive the market size and estimate their future growth prospects on the basis of global, region and country.
Our market research process involves with the four specific stages.
Data Collection: This stage of the market research process involves with the gathering and collecting of the market/industry related data from the sources. There are basically two types of research methods:
Data Synthesis: This stage includes the evaluation and assessment of all the data acquired from the primary and secondary research. It likewise includes in evaluating the information for any disparity watched while information gathering identified with the market. The data & information is gathered with consideration to the heterogeneity of sources. Scientific and statistical methods are implemented for synthesizing dissimilar information sets and provide the relevant data which is fundamental for formulating strategies. Our organization has broad involvement with information amalgamation where the information goes through different stages:
Market Formulation & Deduction: The last stage includes assigning the data & information in a suitable way in order to derive market size. Analyst reviews and domain based opinions based on holistic approach of market estimation combined with industry investigation additionally features a crucial role in this stage.
This stage includes with the finalization of the market size and numbers that we have gathered from primary and secondary research. With the data & information addition, we ensure that there is no gap in the market information. Market trend analysis is finished by our analysts by utilizing data extrapolation procedures, which give the most ideal figures to the market.
Data Validation: Validation is the most crucial step in the process. Validation & re-validation through scientifically designed technique and process that helps us finalize data-points to be used for final calculations. This stage also involves with the data triangulation process. Data triangulation generally implicates the cross validation and matching the data which has been collected from primary and secondary research methods.
Free Customization
Countries can be added on demand
Free yearly update on purchase of Multi/Corporate User License
Companies served till date
We serve our customers 24x7 for 365 days through calls, emails and live chat options.
Huge database of exceptional market reports bringing market intelligence to your fingertips.
SSL enabled, we offer you various secured payment options for risk free purchase.